CPDD 78th Annual Scientific Meeting Program
2016-78th-CPDD-Program-Book-6-07-16FINAL
2016-78th-CPDD-Program-Book-6-07-16FINAL
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
June 16, 2016 Fiesta<br />
Thursday, June 16, 2016<br />
99 Patterns of prescription drug use in Spain: The European opioid treatment patient survey<br />
F. Fonseca 2,4,5 , M. Torrens 2,4,5 , M. Farré 6,4,5 , J. L. Green 1 , I. Maremmani 7,8 , M. Guareschi 8 ,<br />
M. Auriacombe 3 , N. Scherbaum 9 , T. Clausen 10 , D. Hill 11 , R. C. Dart 1 , 1 RADARS System, Denver<br />
Health, Denver, CO, 2 Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Barcelona,<br />
Spain, 3 Addiction Psychiatry (CNRS USR 3413), Universite Bordeaux, Bordeaux, France, 4 Institut<br />
Hospital del Mar d’Investigacions Mèdiques, PSMAR, Barcelona, Spain, 5 Universitat Autònoma<br />
de Barcelona, Barcelona, Spain, 6 Hospital Universitari Germans Trias i Pujol-IGTP, Badalona,<br />
Spain, 7 Department of Neurosciences, Santa Chiara University Hospital, Pisa, Italy, 8 Associazione<br />
per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali, Pietrasanta, Italy, 9 Department<br />
of Psychiatry, LVR Clinic, Essen, Germany, 10 Norwegian Centre for Addiction Research, Oslo,<br />
Norway, 11 NHS Lanarkshire, Motherwell, United Kingdom<br />
100 Alcohol, cannabis, and cigarette use and non-medical prescription drug use stages<br />
B. J. Arterberry 2 , S. R. Horbal 1 , H. Lin 1 , A. Buu 2 , 1 Indiana University, Bloomington, IN,<br />
2<br />
University of Michigan, Ann Arbor, MI<br />
101 Collaborative care for injured patients with prescription drug misuse: A feasibility study<br />
L. K. Whiteside 1 , D. Darnell 2 , K. Jackson 1 , D. Donovan 2,3 , D. Zatzick 2 , 1 Division of<br />
Emergency Medicine, University of Washington, Seattle, WA, 2 Psychiatry and Behavioral<br />
Sciences, University of Washington, Seattle, WA, 3 Alcohol and Drug Abuse Institute,<br />
University of Washington, Seattle, WA<br />
102 Acceptability and feasibility of an intervention for overdose and HIV risk during addictions<br />
treatment for patients with prescription opioid misuse<br />
A. S. Bohnert, M. Walton, F. Blow, L. Thomas, M. llgen, Psychiatry, University of Michigan,<br />
Ann Arbor, MI<br />
103 Change in overdose/poisoning diagnoses in patients prescribed oxycontin after its reformulation<br />
with abuse-deterrent properties<br />
P. Coplan 1 , A. Kadakia 3 , R. Singh 3 , A. DeVeaugh-Geiss 1 , 1 Risk Management and<br />
Epidemiology, Purdue Pharma, Stamford, CT, 3 Purdue, Stamford, CT<br />
104 Timing of sexual abuse, sexual risk behaviors and substance use among U.S. women<br />
M. Cook, Integrated Substance Abuse <strong>Program</strong>s, University of California, Los Angeles, CA<br />
Symposium XV Thursday,<br />
RISKY BUSINESS: NEUROBIOLOGICAL MECHANISMS OF<br />
RISKY DECISION MAKING IN DRUG ABUSE<br />
AND ADDICTION<br />
Chairs: Shelley Su and Carlos Blanco<br />
10/14<br />
10:00 - 12:00 PM<br />
10:00 Dopaminergic modulation of frontal-amygdalar-striatal circuits subserving risk/reward<br />
decision making<br />
Stan Floresco, University of British Columbia, Vancouver, BC, Canada<br />
10:25 Risky decision making, cocaine self-administration, and dopamine signaling<br />
Barry Setlow, University of Florida, Gainesville, FL<br />
10:50 Linking neural networks to markers of dopamine signaling and risky decision-making in<br />
methamphetamine dependence<br />
Milky Kohno, University of California, Los Angeles, CA<br />
11:15 The danger of inadequate risk and reward processing in drug addiction<br />
Martin P Paulus, Laureate Institute for Brain Research, Tulsa, OK<br />
11:40 DISCUSSANT: Risky decision making: towards integrating basic and clinical perspectives<br />
Carlos Blanco, NIH/NIDA/DESPR, Bethesda, MD<br />
101
Change language